RNAZ

RNAZ

USD

TransCode Therapeutics Inc. Common Stock

$9.500-0.410 (-4.137%)

实时价格

Healthcare
生物技术
美国

价格图表

Loading Chart...

关键指标

市场指标
公司基本面
交易统计

市场指标

开盘价

$9.910

最高价

$10.450

最低价

$9.500

成交量

0.01M

公司基本面

市值

8.7M

所属行业

生物技术

国家/地区

United States

交易统计

平均成交量

0.14M

交易所

NCM

货币

USD

52周价格范围

最低价 $6.15当前价 $9.500最高价 $494.34

相关新闻

PR Newswire

TransCode Therapeutics presents preliminary data from its completed Phase 1a study with TTX-MC138 in metastatic disease at ESMO

TransCode Therapeutics, Inc. (NASDAQ: RNAZ) announces completion of Phase 1a clinical trial with TTX-MC138, an investigational inhibitor of...

查看更多
TransCode Therapeutics presents preliminary data from its completed Phase 1a study with TTX-MC138 in metastatic disease at ESMO
PR Newswire

TransCode Therapeutics (RNAZ) announces the acquisition of Polynoma and a $25 Million strategic financing by a subsidiary of CK Life Sciences to form a first-in-class unique immuno-oncology and metastatic prevention oncology company

TransCode Therapeutics, Inc. (NASDAQ: RNAZ) ("TransCode or the "Company") announced today that it entered into a definitive agreement to acquire...

查看更多
TransCode Therapeutics (RNAZ) announces the acquisition of Polynoma and a $25 Million strategic financing by a subsidiary of CK Life Sciences to form a first-in-class unique immuno-oncology and metastatic prevention oncology company